Company: ELV
Filing Date: 2025-04-22
Form Type: 10-Q
Source: 0001156039-25-000057
Chunk: 43

Company: Elevance Health, Inc.
Filing Date: 2025-04-22
Form: 10-Q
Item: Item 8
Chunk 43
---
 before reclassifications, net of tax (expense) benefit of ($60) and $50 respectively193 (162)Amounts reclassified from accumulated other comprehensive income, net of tax expense of ($13) and ($33) respectively42 106 Other comprehensive income (loss)235 (56)Other comprehensive loss attributable to noncontrolling interests, net of tax benefit of $0 and $0 respectively(1)— End of period balance(289)(688)Non-credit components of impairments on investments:Beginning of period balance(2)(3)Other comprehensive income, net of tax expense of $0 and $0 respectively1 — End of period balance(1)(3)Net cash flow hedges:Beginning of period balance(207)(211)Other comprehensive income, net of tax expense of ($3) and ($1) respectively5 2 End of period balance(202)(209)Pension and other postretirement benefits:Beginning of period balance(399)(459)Other comprehensive (loss) income, net of tax expense of ($8) and ($1) respectively(5)4 End of period balance(404)(455)Future policy benefits:Beginning of period balance8 10 Other comprehensive loss, net of tax benefit of $0 and $0 respectively— (2)End of period balance8 8 Foreign currency translation adjustments:Beginning of period balance(24)(18)Other comprehensive income, net of tax expense of $0 and $0 respectively1 — End of period balance(23)(18)Total:Total beginning of period accumulated other comprehensive loss(1,147)(1,313)Total other comprehensive income (loss), net of tax (expense) benefit of ($84) and $15 respectively237 (52)Total other comprehensive loss attributable to noncontrolling interests, net of tax benefit of $0 and $0 respectively(1)— Total end of period accumulated other comprehensive loss$(911)$(1,365)

-30-

14.     Shareholders' Earnings per Share

The denominator for basic and diluted shareholders' earnings per share for the three months ended March 31, 2025 and 2024 is as follows: 20252024Denominator for basic shareholders' earnings per share – weighted-average shares226.4 232.7 Effect of dilutive securities – employee stock options, non-vested restricted stock awards and convertible debentures0.8 1.5 Den